Investigation of Rett syndrome using pluripotent stem cells

Journal of Cellular Biochemistry

Volumn 114, Issue 11, 2013, Pages 2446-2453

  Dajani, Rana ^a,b   Koo, Sung Eun ^c   Sullivan, Gareth J ^d   Park, In Hyun ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HASHEMITE UNIVERSITY   (Jordan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

MeCP2; Reprogramming; Rett syndrome

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; COPY NUMBER VARIATION; DISEASE COURSE; DNA METHYLATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE MUTATION; HISTONE MODIFICATION; HUMAN; IN VITRO STUDY; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RETT SYNDROME; VIRUS GENE;

MECP2; REPROGRAMMING; RETT SYNDROME;

ANIMALS; CELL DIFFERENTIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; METHYL-CPG-BINDING PROTEIN 2; RETT SYNDROME;

EID: 84884221870     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24597     Document Type: Article

References (71)

1. Adachi M, Autry AE, Covington HE III, Monteggia LM,. 2009. MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome. J Neurosci 29: 4218-4227.
2. Adkins NL, Georgel PT,. 2011. MeCP2: Structure and function. Biochem Cell Biol 89: 1-11.
3. Amenduni M, De Filippis R, Cheung AY, Disciglio V, Epistolato MC, Ariani F, Mari F, Mencarelli MA, Hayek Y, Renieri A, Ellis J, Meloni I,. 2011. iPS cells to model CDKL5-related disorders. Eur J Hum Genet 19: 1246-1255.
4. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY,. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188.
5. Ananiev G, Williams EC, Li H, Chang Q,. 2011. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS ONE 6: e25255.
6. Archer H, Evans J, Leonard H, Colvin L, Ravine D, Christodoulou J, Williamson S, Charman T, Bailey ME, Sampson J, de Klerk N, Clarke A,. 2007. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J Med Genet 44: 148-152.
7. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES,. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
8. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, Gnirke A, Eggan K, Meissner A,. 2011. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144: 439-452.
9. Chahrour M, Zoghbi HY,. 2007. The story of Rett syndrome: From clinic to neurobiology. Neuron 56: 422-437.
10. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L,. 2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27: 275-280.
11. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY,. 2010. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468: 263-269.
12. Chao HT, Zoghbi HY, Rosenmund C,. 2007. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56: 58-65.
13. Chen RZ, Akbarian S, Tudor M, Jaenisch R,. 2001. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27: 327-331.
14. Chetty S, Pagliuca FW, Honore C, Kweudjeu A, Rezania A, Melton DA,. 2013. A simple tool to improve pluripotent stem cell differentiation. Nat Meth 10: 553-556.
15. Cheung AY, Horvath LM, Grafodatskaya D, Pasceri P, Weksberg R, Hotta A, Carrel L, Ellis J,. 2011. Isolation of MECP2-null Rett syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet 20: 2103-2115.
16. Chin MH, Pellegrini M, Plath K, Lowry WE,. 2010. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7: 263-269.
17. Davis RL, Weintraub H, Lassar AB,. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51: 987-1000.
18. Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, Guyenet PG, Kipnis J,. 2012. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484: 105-109.
19. Diaz Perez SV, Kim R, Li Z, Marquez VE, Patel S, Plath K, Clark AT,. 2012. Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin. Hum Mol Genet 21: 751-764.
20. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K,. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221.
21. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP,. 2009. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 1: 1.
22. Espuny-Camacho I, Michelsen KA, Gall D, Linaro D, Hasche A, Bonnefont J, Bali C, Orduz D, Bilheu A, Herpoel A, Lambert N, Gaspard N, Peron S, Schiffmann SN, Giugliano M, Gaillard A, Vanderhaeghen P,. 2013. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77: 440-456.
23. Evans JC, Archer HL, Whatley SD, Clarke A,. 2006. Germline mosaicism for a MECP2 mutation in a man with two Rett daughters. Clin Genet 70: 336-338.
24. Farra N, Zhang WB, Pasceri P, Eubanks JH, Salter MW, Ellis J,. 2012. Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol Psychiatr 17: 1261-1271.
25. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M,. 2009. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85: 348-362.
26. Fyffe SL, Neul JL, Samaco RC, Chao HT, Ben-Shachar S, Moretti P, McGill BE, Goulding EH, Sullivan E, Tecott LH, Zoghbi HY,. 2008. Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 59: 947-958.
27. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS, Zhang K,. 2011. Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-67.
28. Grillo E, Villard L, Clarke A, Ben Zeev B, Pineda M, Bahi-Buisson N, Hryniewiecka-Jaworska A, Bienvenu T, Armstrong J, Roche-Martinez A, Mari F, Veneselli E, Russo S, Vignoli A, Pini G, Djuric M, Bisgaard AM, Mejaski Bosnjak V, Polgar N, Cogliati F, Ravn K, Pintaudi M, Melegh B, Craiu D, Djukic A, Renieri A,. 2012. Rett networked database: An integrated clinical and genetic network of Rett syndrome databases. Hum Mutat 33: 1031-1036.
29. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R, Young RA,. 2010. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7: 249-257.
30. Gurdon JB,. 1962. Adult frogs derived from the nuclei of single somatic cells. Dev Biol 4: 256-273.
31. Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW, Jaenisch R,. 2010. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA 107: 9222-9227.
32. Hotta A, Cheung AY, Farra N, Vijayaragavan K, Seguin CA, Draper JS, Pasceri P, Maksakova IA, Mager DL, Rossant J, Bhatia M, Ellis J,. 2009. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 6: 370-376.
33. Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC,. 2010. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 107: 4335-4340.
34. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, Ng S, Sourour M, Hamalainen R, Olsson C, Lundin K, Mikkola M, Trokovic R, Peitz M, Brustle O, Bazett-Jones DP, Alitalo K, Lahesmaa R, Nagy A, Otonkoski T,. 2011. Copy number variation and selection during reprogramming to pluripotency. Nature 471: 58-62.
35. Hysolli E, Jung YW, Tanaka Y, Kim KY, Park IH,. 2012. The lesser known story of X chromosome reactivation: A closer look into the reprogramming of the inactive X chromosome. Cell Cycle 11: 229-235.
36. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E,. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
37. Joung JK, Sander JD,. 2013. TALENs: A widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14: 49-55.
38. Kim DS, Lee JS, Leem JW, Huh YJ, Kim JY, Kim HS, Park IH, Daley GQ, Hwang DY, Kim DW,. 2010. Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev 6: 270-281.
39. Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, Huo H, Loh YH, Aryee MJ, Lensch MW, Li H, Collins JJ, Feinberg AP, Daley GQ,. 2011a. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 29: 1117-1119.
40. Kim KY, Hysolli E, Park IH,. 2011b. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci USA 108: 14169-14174.
41. Lengner CJ, Gimelbrant AA, Erwin JA, Cheng AW, Guenther MG, Welstead GG, Alagappan R, Frampton GM, Xu P, Muffat J, Santagata S, Powers D, Barrett CB, Young RA, Lee JT, Jaenisch R, Mitalipova M,. 2010. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141: 872-883.
42. Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK, Hirrlinger PG, Kirchhoff F, Bissonnette JM, Ballas N, Mandel G,. 2011. A role for glia in the progression of Rett's syndrome. Nature 475: 497-500.
43. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR,. 2011. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471: 68-73.
44. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM,. 2013. RNA-guided human genome engineering via Cas9. Science 339: 823-826.
45. Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y, Chen G, Gage FH, Muotri AR,. 2010. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143: 527-539.
46. Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R, Scala E, Longo I, Grosso S, Pescucci C, Ariani F, Hayek G, Balestri P, Bergo A, Badaracco G, Zappella M, Broccoli V, Renieri A, Kilstrup-Nielsen C, Landsberger N,. 2005. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 14: 1935-1946.
47. Maroof AM, Keros S, Tyson JA, Ying SW, Ganat YM, Merkle FT, Liu B, Goulburn A, Stanley EG, Elefanty AG, Widmer HR, Eggan K, Goldstein PA, Anderson SA, Studer L,. 2013. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 12: 559-572.
48. Mekhoubad S, Bock C, de Boer AS, Kiskinis E, Meissner A, Eggan K,. 2012. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 10: 595-609.
49. Mussolino C, Morbitzer R, Lutge F, Dannemann N, Lahaye T, Cathomen T,. 2011. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucl Acids Res 39: 9283-9293.
50. Okita K, Ichisaka T, Yamanaka S,. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
51. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, Cowan CA, Chien KR, Melton DA,. 2008. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 26: 313-315.
52. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ,. 2008a. Disease-specific induced pluripotent stem cells. Cell 134: 877-886.
53. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ,. 2008b. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
54. Pattanayak V, Ramirez CL, Joung JK, Liu DR,. 2011. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Method 8: 765-770.
55. Renieri A, Meloni I, Longo I, Ariani F, Mari F, Pescucci C, Cambi F,. 2003. Rett syndrome: The complex nature of a monogenic disease. J Mol Med (Berl) 81: 346-354.
56. Rett A,. 1966. On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 116: 723-726.
57. Ricceri L, De Filippis B, Laviola G,. 2008. Mouse models of Rett syndrome: From behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav Pharmacol 19: 501-517.
58. Ricciardi S, Ungaro F, Hambrock M, Rademacher N, Stefanelli G, Brambilla D, Sessa A, Magagnotti C, Bachi A, Giarda E, Verpelli C, Kilstrup-Nielsen C, Sala C, Kalscheuer VM, Broccoli V,. 2012. CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. Nat Cell Biol 14: 911-923.
59. Samaco RC, Mandel-Brehm C, Chao HT, Ward CS, Fyffe-Maricich SL, Ren J, Hyland K, Thaller C, Maricich SM, Humphreys P, Greer JJ, Percy A, Glaze DG, Zoghbi HY, Neul JL,. 2009. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci USA 106: 21966-21971.
60. Schanen C, Houwink EJ, Dorrani N, Lane J, Everett R, Feng A, Cantor RM, Percy A,. 2004. Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J Med Genet A 126A: 129-140.
61. Siller R, Greenhough S, Park IH, Sullivan GJ,. 2013. Modelling human disease with pluripotent stem cells. Curr Gene Ther 13: 99-110.
62. Sohn YD, Han JW, Yoon YS,. 2012. Generation of induced pluripotent stem cells from somatic cells. Prog Mol Biol Transl Sci 111: 1-26.
63. Soldner F, Laganiere J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, Khurana V, Golbe LI, Myers RH, Lindquist S, Zhang L, Guschin D, Fong LK, Vu BJ, Meng X, Urnov FD, Rebar EJ, Gregory PD, Zhang HS, Jaenisch R,. 2011. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146: 318-331.
64. Song JJ, Ott HC,. 2011. Organ engineering based on decellularized matrix scaffolds. Trends Mol Med 17: 424-432.
65. Surani MA,. 2012. Cellular reprogramming in pursuit of immortality. Cell Stem Cell 11: 748-750.
66. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S,. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
67. Takahashi K, Yamanaka S,. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
68. Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OL, Archer H, Evans J, Clarke A, Pelka GJ, Tam PP, Watson C, Lahooti H, Ellaway CJ, Bennetts B, Leonard H, Gecz J,. 2004. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 75: 1079-1093.
69. Weng SM, Bailey ME, Cobb SR,. 2011. Rett syndrome: From bed to bench. Pediatr Neonatol 52: 309-316.
70. Young JI, Zoghbi HY,. 2004. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome. Am J Hum Genet 74: 511-520.
71. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA,. 2009. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.